Top Stories

The New Mexico Independent going forward

By | 11.16.11

I am writing today to announce the closure of the New Mexico Independent. After three and a half years of operation in New Mexico, the board of the American Independent News Network, has decided to shift publication of its news…

EIB hears more anti-cap-and-trade testimony

Mesa Verde 80
By | 11.10.11

While environmental activists played their part yesterday during demonstrations at the capitol building, going so far as to dress up as solar panels and to sing the tune of “You Are My Sunshine,” their counterparts, the anti-cap-and-trade contingency who has…

New Mexico’s largest university low in popularity

jobs-80
By | 11.10.11

Roughly one quarter of University of New Mexico students are unimpressed with the state’s flagship public school, according to a survey that questioned college students about their higher education experiences.

NM veteran debates VA medical marijuana policy on Fox News

By | 03.19.10 | 12:00 pm


Fox News picked up on our story about New Mexico veterans with PTSD and the Veterans Administration policy that prevents doctors from helping PTSD patients get medical marijuana. Paul Culkin, the founder of New Mexico Medical Marijuana Patient’s Group, whom we interviewed for our story, debated the benefits of medical marijuana with Dr. Andrea Bothwell on the Fox News show Fair & Balanced. Culkin is an Iraqi war veteran who suffers from Post Traumatic Stress Disorder, or PTSD. He described the benefits of medical marijuana for treating his own condition after other prescribed medications didn’t work. Bothwell defended the VA’s policy of not allowing its doctor’s to recommend medical marijuana because it isn’t FDA approved due to a lack of clinical data. Culkin noted that because marijuana is classified by the federal government as a schedule one drug, the Drug Enforcement Agency hinders appropriate studies. Bothwell countered that there had been numerous studies but that researchers lack a standardized product to study.  She concluded that there are two FDA approved drugs available for PTSD.

Comments